CTOs on the Move

Owl Insights

www.owlinsights.com

 
Transforming Behavioral Health Care with Data, Evidence and Insights. Owl Insights is the leading provider of precision-guided behavioral health (BH) care management technology.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Owl Insights raised $15M on 09/08/2020

Similar Companies

Frontage Laboratories

Frontage Laboratories, Inc. is a CRO that provides integrated, science-driven, product development services throughout the drug discovery and development process to enable pharmaceutical and biotechnology companies to achieve their development goals. Comprehensive services include drug metabolism and pharmacokinetics, analytical testing and formulation development, preclinical and clinical trial material manufacturing, bioanalysis, preclinical safety and toxicology assessment and early phase clinical studies. Frontage has enabled many biotechnology companies and leading pharmaceutical companies of varying sizes to advance a myriad of molecules through development and file regulatory submissions in the United States, China and other countries.

HAIR & SKIN

HAIR & SKIN is a company that operates modern and fully digitalized clinics in pedestrian areas throughout Switzerland, with a focus on skin and hair treatments at fair prices.

Healthcare Anchor Network

Healthcare Anchor Network is a collaboration of over 65 healthcare systems in the United States that are committed to leveraging their institutional assets to improve health and well-being by addressing economic and racial inequities in the communities...

Excerpta Medica

Excerpta Medica is a Bridgewater, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Certara

Certara is a leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes. Certara`s solutions, which span the drug development and patient care lifecycle, help increase the probability of regulatory and commercial success by using the most scientifically advanced modeling and simulation technologies and regulatory strategies. Its clients include hundreds of global biopharmaceutical companies, leading academic institutions and key regulatory agencies.